Home-based gentle brain and nerve stimulation for children with cerebral palsy
Tests a home stimulation device in children and teenagers with cerebral palsy.
Key facts
- Who runs it
- KK Women's and Children's Hospital
- Where
- Singapore2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- A Novel Home-based Non-invasive Neuromodulation Therapy for Children and Adolescents With Cerebral Palsy
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 11 Oct 2024
- Planned end
- Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- AscenZ-IV neuromodulation device
- Record updated
- 10 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with spastic cerebral palsy to test a home-based brain and nerve stimulation device (AscenZ-IV Stimulator). Families, staff and clinicians may join interviews.
- Age
- The criteria say 2 to under 21 years. The registry age fields say 6 Years to 21 Years.
- Sex
- All sexes can join.
- Disease stage
- Mild to severe spastic cerebral palsy, Gross Motor Function Classification System (GMFCS) level II, III, IV or V.
- Earlier treatment
- No botulinum toxin injections into muscle within the last 6 months. No muscle, bone, brain or nerve surgery within the last 6 months. No major surgery with a hospital stay over 1 week within the last 3 months.
Main reasons for not taking part
- Epilepsy with a seizure in the last 12 months, or uncontrolled epilepsy
- History of brain tumour, brain injury or mental illness
- An implanted electrical device such as a pacemaker or defibrillator, or devices affected by magnets such as programmable shunts
- Pregnancy
- No parent or caregiver with at least simple English; people who refuse audio recording cannot join the interviews
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Children and adolescents aged between 2 to <21 years old with mild to severe Spastic Cerebral Palsy (CP) classified on Gross Motor Function Classification System (GMFCS) II, III, IV, V. Families with at least one parent or caregiver has simple or conversational English language skill
- To be eligible for the qualitative interview components of this research study, the individuals should be recognised as one of the following:
- CP patients who participate in this research study,
- caregivers of the CP patients taking part in this research study,
- implementation staff
- qualified clinicians not involved in the intervention or refused to recommend the intervention device (AscenZion-IV stimulator) for management of CP; Eligible individuals must agree to be audio-recorded
Who cannot take part
- CP patients who received any intramuscular botulinum toxin injections within less than 6 months (as anti-spasticity effect lasts for 4-6 months)
- CP patients who received any musculo-skeletal, brain or nerve-related surgery within less than 6 months, or major surgery requiring prolonged hospitalisation (\>1week) within less than 3 months; Those who do not agree to be audio-recorded will be excluded for the qualitative interview components of this research study
- CP patients with epilepsy with recent seizures (\<12 months) will be excluded for safety given the theoretical risks of seizures (abnormal brain electrical discharges) with transcranial electrical stimulation. We will include those with well controlled epilepsy with no recent seizures (within 12 months)
- CP patients who have contra-indications to the use of tPCS and/or TENS will be excluded from the study, include:; Individuals with history of uncontrolled epileptic disorder, seizures, brain tumour or trauma, and mental disease; Individuals with electrical implanted stimulatory device, such as pacemaker or defibrillator; Individuals with medical devices that are affected by magnets, such as programmable shunts; Individuals with pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 6 and 21 years old?
This trial is currently available in Singapore.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to evaluate the clinical effectiveness, feasibility and acceptability of a novel home-based noninvasive neuromodulation therapy (AscenZ-IV Stimulator) that utilizes transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) for children and adolescents with cerebral palsy as a community-based intervention by families and healthcare providers.
The 2 groups in the trial
- Intervention: Standard care + AscenZ-IV StimulationTreatment being tested
Participants randomized as Group 1 first receive both standard care (existing medical interventions, therapy program) and AscenZ-IV Stimulation for 8 weeks (30min/day; 5 to 7 sessions/week, additional 30min/day; 5 to 7 sessions/week for behavioral and drooling issues if necessary). Then, they receive standard care only for another 8 weeks. For participants randomized as Group 2, control condition precedes intervention condition. Subsequently, participants are given the option to receive an additional 4 weeks of intervention for maintenance
Treatment: AscenZ-IV neuromodulation device
- Control: Standard care onlyNo study treatment, for comparison
Participants randomized as Group 1 first receive both standard care (existing medical interventions, therapy program) and AscenZ-IV Stimulation for 8 weeks (30min/day; 5 to 7 sessions/week, additional 30min/day; 5 to 7 sessions/week for behavioral and drooling issues if necessary). Then, they receive standard care only for another 8 weeks. For participants randomized as Group 2, control condition precedes intervention condition. Subsequently, participants are given the option to receive an additional 4 weeks of intervention for maintenance
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Novel Home-based Non-invasive Neuromodulation Therapy for Children and Adolescents With Cerebral Palsy
- Plain-language title
- Home-based gentle brain and nerve stimulation for children with cerebral palsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06921538, who can take part
- Record updated
- 10 April 2025